{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:10:15Z","timestamp":1785845415308,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s15006-016-8303-0","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T08:51:07Z","timestamp":1464166267000},"page":"7-11","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Unzureichende Symptomkontrolle unter Langzeittherapie mit PPI bei GERD \u2014 Fakt oder Fiktion?","Insufficient symptom control under long-term treatment with PPI in GERD \u2014 fact or fiction?"],"prefix":"10.1007","volume":"158","author":[{"name":"LOPA-Studiengruppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Labenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Willeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,25]]},"reference":[{"issue":"5Suppl","key":"8303_CR1","first-page":"A295","volume":"3","author":"SE Attwood","year":"2015","unstructured":"Attwood SE, Leontiadis GI, Rodriguez L, Siersema P, Labenz J. Global clinical experience with EndoStim\u00ae lower esophageal sphincter stimulation therapy: An individual patient data meta-analysis of the open label clinical trials. UEG Journal 2015; 3(5Suppl): A295.","journal-title":"UEG Journal"},{"issue":"7","key":"8303_CR2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/gutjnl-2013-306393","volume":"63","author":"G Boeckxstaens","year":"2014","unstructured":"Boeckxstaens G, El-Serag HB, Smout AJPM, Kahrilas PJ. Symptomatic reflux disease: the present, the past and the future. Gut 2014; 63(7): 1185\u20131193.","journal-title":"Gut"},{"issue":"5","key":"8303_CR3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/SLA.0b013e3181fd879b","volume":"252","author":"L Bonavina","year":"2010","unstructured":"Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg 2010; 252(5): 857\u2013862.","journal-title":"Ann Surg"},{"issue":"7","key":"8303_CR4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","volume":"63","author":"HB El-Serag","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2014; 63(7): 871\u2013880.","journal-title":"Gut"},{"issue":"6","key":"8303_CR5","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","volume":"32","author":"HB El-Serag","year":"2010","unstructured":"El-Serag HB, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 2010; 32(6): 720\u2013737.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"8303_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","volume":"58","author":"R Fass","year":"2009","unstructured":"Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58(2): 295\u2013309.","journal-title":"Gut"},{"issue":"1","key":"8303_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1542-3565(05)00860-8","volume":"4","author":"R Fass","year":"2006","unstructured":"Fass R, Sontag SJ, Traxler B, Sostek M. Treatment of patients with persistent heartburn symptoms: a double- blind, randomized trial. Clin Gastroenterol Hepatol 2006; 4(1): 50\u201356.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"8303_CR8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1205544","volume":"368","author":"R Ganz","year":"2013","unstructured":"Ganz R, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med 2013; 368(8): 719\u2013727.","journal-title":"N Engl J Med"},{"issue":"443","key":"8303_CR9","first-page":"463","volume":"49","author":"AP Hungin","year":"1999","unstructured":"Hungin AP, Rubin G, O \u2019Flanagan H. Factors influencing compliance in long-term proton pump inhibitor therapy in general practice. Br J Gen Pract 1999; 49(443): 463\u2013464.","journal-title":"Br J Gen Pract"},{"issue":"5","key":"8303_CR10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/apt.12204","volume":"37","author":"C Jonasson","year":"2013","unstructured":"Jonasson C, Wernersson B, Hoff DA, Hatlebakk JG. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2013; 37(5): 564\u2013572.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"8303_CR11","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/apt.13306","volume":"42","author":"WFW Kappelle","year":"2015","unstructured":"Kappelle WFW, Bredenoord AJ, Conchillo JM, et al. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease \u2014 interim results of an international multicentre trial. Aliment Pharmacol Ther 2015; 42(5): 614\u2013625.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"8303_CR12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1055\/s-0034-1385202","volume":"52","author":"H Koop","year":"2014","unstructured":"Koop H, Fuchs KH, Labenz J, et al. und die Mitarbeiter der Leitliniengruppe: S2k-Leitlinie: Gastro\u00f6sophageale Refluxkrankkheit unter Federf\u00fchrung der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). AWMF Register Nr. 021-013. Z Gastroenterol 2014; 52(11): 1299\u20131346.","journal-title":"Z Gastroenterol"},{"issue":"2","key":"8303_CR13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11377-016-0045-0","volume":"11","author":"J Labenz","year":"2016","unstructured":"Labenz J, Labenz C. Pr\u00e4valenz und nat\u00fcrlicher Verlauf der gastro\u00f6sophagealen Refluxkrankheit. Gastroenterologe 2016; 11(2): 102\u2013109.","journal-title":"Gastroenterologe"},{"issue":"5","key":"8303_CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11377-009-0290-6","volume":"4","author":"J Labenz","year":"2009","unstructured":"Labenz J, Feu\u00dfner H. Therapieresistente Refluxkrankheit. Wie und wie lange medikament\u00f6s therapieren? Wann operieren? Gastroenterologe 2009; 4(5): 393\u2013402.","journal-title":"Gastroenterologe"},{"issue":"1","key":"8303_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/dote.12293","volume":"29","author":"R Mandaliya","year":"2016","unstructured":"Mandaliya R, DiMarino AJ, Cohen S. Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy. Dis Esophagus 2016; 29(1): 27\u201333.","journal-title":"Dis Esophagus"},{"issue":"1","key":"8303_CR16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1365-2036.2006.02727.x","volume":"23","author":"M Nocon","year":"2006","unstructured":"Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux \u2014 a population-based study. Aliment Pharmacol Ther 2006; 23(1): 169\u2013174.","journal-title":"Aliment Pharmacol Ther"},{"key":"8303_CR17","doi-asserted-by":"crossref","unstructured":"Reimer C, L\u00f8drup AB, Smith G, Wilkinson J, Bytzer P. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor. Aliment Pharmacol Ther 2016; Feb 22. [Epub ahead of print]","DOI":"10.1111\/apt.13567"},{"issue":"3","key":"8303_CR18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.surg.2014.10.012","volume":"157","author":"L Rodriguez","year":"2015","unstructured":"Rodriguez L, Rodriguez P, G\u00f3mez B, et al. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease. Surgery 2015; 157(3): 556\u2013567.","journal-title":"Surgery"},{"key":"8303_CR19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1055\/s-0033-1344213","volume":"45","author":"L Rodriguez","year":"2013","unstructured":"Rodriguez L, Rodriguez P, G\u00f3mez B, et al. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease. Endoscopy 2013; 45: 595\u2013604.","journal-title":"Endoscopy"},{"key":"8303_CR20","doi-asserted-by":"crossref","unstructured":"Rodriguez L, Rodriguez P, G\u00f3mez B, Netto MG, Crowell MD, Soffer E. Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: long-term 3-year results. Surg Endosc 2015; Oct 20. [Epub ahead of print]","DOI":"10.1007\/s00464-015-4539-5"},{"key":"8303_CR21","doi-asserted-by":"crossref","first-page":"A294","DOI":"10.1177\/2050640615572176","volume":"3","author":"HG Schulz","year":"2015","unstructured":"Schulz HG, Leodolter A, Pedersen JB, Eypasch E, Labenz J. Preliminary results of a prospective multicenter observational registry of lower esophageal sphincter stimulation for GERD: The LESS-GERD registry. UEG Journal 2015; 3: A294\u2013295.","journal-title":"UEG Journal"},{"issue":"9","key":"8303_CR22","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/gutjnl-2011-301897","volume":"61","author":"D Sifrim","year":"2012","unstructured":"Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut 2012; 61(9): 1340\u20131354.","journal-title":"Gut"},{"issue":"8","key":"8303_CR23","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101(8): 1900\u20131920.","journal-title":"Am J Gastroenterol"},{"key":"8303_CR24","doi-asserted-by":"crossref","unstructured":"Warren HF, Reynolds JL, Lipham JC, et al. Multiinstitutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease. Surg Endosc 2015; 2015 Nov 5. Epub ahead of print","DOI":"10.1007\/s00464-015-4659-y"},{"issue":"10","key":"8303_CR25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/j.1365-2036.2010.04469.x","volume":"32","author":"C Wilder-Smith","year":"2010","unstructured":"Wilder-Smith C, R\u00f6hss K, Bokelund Singh S. The effects of dose and timing of esomeprazole administration on 24-h, daytime and night-time acid inhibition in healthy volunteers. Aliment Pharmacol Ther 2010; 32(10): 1249\u20131256.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-016-8303-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-016-8303-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-016-8303-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T11:15:56Z","timestamp":1656587756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-016-8303-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":25,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["8303"],"URL":"https:\/\/doi.org\/10.1007\/s15006-016-8303-0","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}